Voloridge Investment Management, LLC Ascendis Pharma A/S Transaction History

Voloridge Investment Management, LLC

$26.2 Billion
Q2 2024

A detailed history of Voloridge Investment Management, LLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Voloridge Investment Management, LLC holds 346,218 shares of ASND stock, worth $51 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

346,218

Previous 307,499 12.59%

Holding current value

$51 Million

Previous $46.5 Million 1.58%

% of portfolio

0.18%

Previous 0.17%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$121.07 - $153.67 $4.69 Million - $5.95 Million	38,719 Added 12.59%	346,218 $47.2 Million
Q1 2024 May 15, 2024	BUY	$123.45 - $159.4 $28.9 Million - $37.3 Million	234,164 Added 319.31%	307,499 $46.5 Million
Q4 2023 Feb 14, 2024	BUY	$86.1 - $127.36 $4.6 Million - $6.8 Million	53,427 Added 268.37%	73,335 $9.24 Million
Q3 2023 Nov 14, 2023	BUY	$86.5 - $103.97 $1.72 Million - $2.07 Million	19,908 New	19,908 $1.86 Million
Q2 2022 Aug 15, 2022	SELL	$78.08 - $117.61 $147,336 - $221,930	-1,887 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$102.18 - $135.75 $283,242 - $376,299	-2,772 Reduced 59.5%	1,887 $221,000
Q4 2021 Feb 14, 2022	SELL	$127.1 - $169.66 $215,434 - $287,573	-1,695 Reduced 26.68%	4,659 $627,000
Q3 2021 Nov 15, 2021	BUY	$112.67 - $176.92 $715,905 - $1.12 Million	6,354 New	6,354 $1.01 Million
Q1 2021 May 17, 2021	SELL	$124.92 - $173.33 $701,800 - $973,767	-5,618 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$151.2 - $182.76 $217,576 - $262,991	-1,439 Reduced 20.39%	5,618 $937,000
Q3 2020 Nov 16, 2020	BUY	$134.29 - $154.32 $15,577 - $17,901	116 Added 1.67%	7,057 $1.09 Million
Q2 2020 Aug 14, 2020	BUY	$110.87 - $156.01 $769,548 - $1.08 Million	6,941 New	6,941 $1.03 Million
Q1 2020 May 15, 2020	SELL	$97.01 - $145.11 $3.28 Million - $4.9 Million	-33,800 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$91.45 - $139.12 $863,196 - $1.31 Million	9,439 Added 38.75%	33,800 $4.7 Million
Q3 2019 Nov 14, 2019	BUY	$95.8 - $118.9 $2.14 Million - $2.65 Million	22,291 Added 1076.86%	24,361 $2.35 Million
Q2 2019 Aug 14, 2019	SELL	$107.11 - $132.09 $513,699 - $633,503	-4,796 Reduced 69.85%	2,070 $238,000
Q1 2019 May 15, 2019	BUY	$62.15 - $129.99 $426,721 - $892,511	6,866 New	6,866 $808,000

Others Institutions Holding ASND

# of Institutions

223

Shares Held

56.5M

Call Options Held

142K

Put Options Held

259K

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $8.22B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.

Account

Voloridge Investment Management, LLC Ascendis Pharma A/S Transaction History